Therapeutics
Review: anticholinergics but not ß2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPD
Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006;21:10119.[CrossRef][Medline]
Q How effective are anticholinergics and ß2 agonists for chronic obstructive pulmonary disease (COPD)?






IM/Ambulatory care 





Respirology 





Key Words: adrenergic beta-agonists albuterol bronchodilator agents ethanolamines lung diseases (obstructive)
| The first 150 words of the full text of this article appear below. |
Data sources:
Medline, EMBASE/Excerpta Medica, and Cochrane databases (to December 2005); US Food and Drug Administration website; and references of identified reviews.
Study selection and assessment:
randomised controlled trials (RCTs) in any language that compared anticholinergics or ß2 agonists with placebo or with each other; had
3 month follow up; and reported COPD exacerbations requiring study withdrawal or hospital admission, or respiratory death. 22 RCTs (n = 15 276, mean age range 6064 y) with mean 20 month follow up (range 360 mo) met the selection criteria. Methodological quality of individual studies was based on randomisation procedure and allocation concealment, blinding of patients and providers, reporting of withdrawals and dropouts, and intention to treat analysis.
Outcomes:
exacerbations causing withdrawal from the study, severe exacerbations requiring hospital admission, and respiratory death.
Anticholinergics used were ipratropium and tiotropium. ß2 agonists used were albuterol, metaproterenol, formoterol, and salmeterol. Compared with placebo, anticholinergics reduced
University of Miami, Miller School of Medicine,
Miami, Florida, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
